Extended release quetiapine fumarate in major depressive disorder: analysis in patients with anxious depression
Thase, Michael E × Demyttenaere, Koen Earley, Willie R Gustafsson, Urban Udd, Mattias Eriksson, Hans #
Depression and Anxiety vol:29 issue:7 pages:574-586
A pooled analysis was performed on data from two studies evaluating the efficacy of once-daily extended-release quetiapine fumarate (quetiapine XR) monotherapy for patients with major depressive disorder. Through these analyses (based on Hamilton Rating Scale for Depression (HAM-D) and Hamilton Rating Scale for Anxiety (HAM-A) measures), we aim to further evaluate the efficacy of quetiapine XR in depressed patients with high levels of anxiety symptoms.